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Background: Bacterial steroid monooxygenase degrades progesterone.
Results: The crystallographic and mutagenesis analysis outline a robust active-site scaffold, capable of performing Baeyer-
Villiger oxidations on chemically diverse molecules.
Conclusion: This and related enzymes represent a fascinating case for the comparative evaluation of user tailored protein
engineering with enzyme variants arising through evolution.
Significance: These findings highlight the biocatalytic potential of Baeyer-Villiger monooxygenases.
Steroid monooxygenase (STMO) from Rhodococcus rhodo-
chrous catalyzes the Baeyer-Villiger conversion of progesterone
into progesterone acetate using FAD as prosthetic group and
NADPHas reducing cofactor. The enzyme shares high sequence
similarity with well characterized Baeyer-Villiger monooxyge-
nases, including phenylacetone monooxygenase and cyclo-
hexanone monooxygenase. The comparative biochemical and
structural analysis of STMO can be particularly insightful with
regard to the understanding of the substrate-specificity proper-
ties of Baeyer-Villiger monooxygenases that are emerging as
promising tools in biocatalytic applications and as targets for
prodrug activation. The crystal structures of STMO in the
native, NADP-bound, and two mutant forms reveal structural
details on this microbial steroid-degrading enzyme. The bind-
ing of the nicotinamide ring of NADP is shifted with respect to
the flavin compared with that observed in other monooxyge-
nases of the same class. This finding fully supports the idea that
NADP(H) adopts various positions during the catalytic cycle to
perform its multiple functions in catalysis. The active site
closely resembles that of phenylacetone monooxygenase. This
observation led us to discover that STMO is capable of acting
also on phenylacetone, which implies an impressive level of sub-
strate promiscuity. The investigation of six mutants that target
residues on the surface of the substrate-binding site reveals that
enzymatic conversions of both progesterone and phenylacetone
are largely insensitive to relatively drastic amino acid changes,
with somemutants evendisplaying enhanced activity onproges-
terone. These features possibly reflect the fact that these
enzymes are continuously evolving to acquire new activities,
depending on the emerging availabilities of new compounds in
the living environment.
Baeyer-Villiger monooxygenases (BVMO)3 use flavin cofac-
tors to catalyze the insertion of an oxygen atom into ketone
substrates to generate esters and/or lactones (1). NADPH and
molecular oxygen represent the electron and oxygen-atom
donors in the reaction, respectively. Since their discovery more
than 60 years ago (2, 3), these enzymes have attracted consid-
erable interest for their potential applicability in industrial bio-
catalysis, their role as (pro)drug targets, and their value as
model systems to study how enzymes carry out a classical
organic chemistry reaction (4).
In mechanistic terms, BVMOs display two key features: (i)
the activation of molecular oxygen through formation of a
covalent intermediate, the flavin-peroxide, formed by the reac-
tion of the reduced flavinwith oxygen, and (ii) the occurrence of
a tetrahedral Criegee intermediate in substrate oxygenation,
which is analogous to the intermediate of nonenzymatic
Baeyer-Villiger oxidations (5–7). NADP(H) plays a key role in
the whole process by functioning not only as a reductant of the
flavin but also as an integral part of the active site that promotes
flavin-peroxide and Criegee intermediate formation and stabi-
lization. In more detail, the reaction starts with the two-elec-
tron reduction of the flavin byNADPH.Next, the reduced pros-
thetic group reacts with oxygen to generate the flavin-peroxide,
which is responsible for the insertion of an oxygen atom into
the substrate to generate the oxygenated product. The reaction
endswith the regeneration of the oxidized flavin and the release
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Supplemental Material can be found at:
of NADP. Importantly, the flavin-peroxide forms only if
NADP is bound to the active site. Indeed, an artificial elec-
tron-donor (such as dithionite) does not enable the enzyme to
perform the catalytic reaction. These features imply that
NADP(H) must have at least two binding modes; one compe-
tent in flavin reduction and one capable of promoting forma-
tion and stabilization of the crucial flavin-peroxide.
Cyclohexanone monooxygenase (CHMO) was the first
BVMO that could be produced in a recombinant manner and
has been subject to in-depth enzymological studies (5). In 1999,
steroid monooxygenase (STMO) from Rhodococcus rhodo-
chrous was the second BVMO for which the gene was cloned
and used for heterologous expression (8). However, so far no
subsequent studies on this bacterial steroid degrading
monooxygenase have been reported. More recently, phenyl-
acetone monooxygenase (PAMO) became another model sys-
tem especially after its three-dimensional crystal structure was
solved (9). An excellent review about the history and state of the
art of the field has been recently published by Lau and co-work-
ers (1).
Genome sequencing has led to the discovery of a huge num-
ber of BVMOs in bacteria and fungi (10). The enzymes display
a bewildering diversitywith regard to substrate preferences that
can range from small molecules, such as small aromatic and
aliphatic compounds, to large macrocyclic compounds typi-
cally used as intermediates in the biosynthesis of complex
metabolites such as alkaloids and antibiotics. The crystal struc-
tures of several BVMOs have been solved in the past few years
including those of CHMO (11), PAMO (9), 2-oxo-3-4,5,5-
trimethylcyclopentenylacetyl-CoAmonooxygenase (OTEMO)
(12), MtmOIV (a Baeyer-Villiger monooxygenase involved in
mithramycin biosynthesis) (13), and a NAD(P)H-dependent
monooxygenase from a marine bacterium that is more closely
related to flavin-containing monoxygenases (also known as
FMOs) (14). The common features shared by these crystal
structures have established a solid structural framework to
study enzyme-mediated Baeyer-Villiger oxidations, especially
with regard to the existence of conformational changes and the
role of NADP(H) and conserved residues for intermediate sta-
bilization (7, 11). Furthermore, the combination of structural
and enzyme engineering studies has provided important hints
about the protein elements that determine the substrate selec-
tivity of the enzymes. For instance, a loop in direct contact with
the pyrimidine ring of the flavin has been shown to be crucial
for substrate binding (15). On the other hand, especially with
the aim of exploiting these enzymes for biocatalytic purposes,
we need to further understand and rationalize their substrate
specificity properties.
In this context, here we describe the structural elucidation
complemented by site-directed mutagenesis studies of STMO
from R. rhodochrous, which was originally discovered by
Miyamoto et al. (16). This enzyme is capable of converting pro-
gesterone into progesterone acetate (Scheme 1). The interest
for this enzyme stems from its high sequence homology with
the most well characterized BVMOs with known crystal struc-
tures (8, 17); STMO has 53% sequence identity with PAMO
from Thermobifida fusca, 45% with CHMO from Rhodococcus
sp. strain HI-31, and 43% with OTEMO from Pseudomonas
putida. The inspiration for our study was to compare these
closely related enzymes, which exhibit so diverse substrate
preferences ranging from a simple aromatic (phenylacetone)
molecule to a steroid. The close evolutionary relatedness adds
value to our approach because it allows the identification of
structural elements that direct substrate binding and selectiv-
ity. Our analysis reveals that especially PAMO and STMOhave
highly similar active sites to the point that STMO is shown to be
active also on phenylacetone. Such promiscuity in substrate
preference has interesting implications for BVMO evolution,
function, redesign, and biocatalytic applications.
SCHEME 1. Reactions catalyzed by STMO (insertion of an oxygen between C17 and C20 carbons of 11 - and 11-hydroxyprogesterone) and
PAMO.
SteroidMonooxygenase from R. rhodochrous
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Cloning, Expression, and Purification—The gene coding for
STMO from R. rhodochrous (8) was cloned into a ChampionTM
pET-vector (Invitrogen) for overexpression in Escherichia coli.
The resulting protein contained a N-terminal His6-tagged
SUMO, which can be removed by SUMO protease. The plas-
mid was transformed into E. coli strain BL21(DE3) CodonPlus.
The resulting colonies were preinoculated into LB broth sup-
plemented with kanamycin (50 g/ml) and chloramphenicol
(50 g/ml) and grown overnight at 37 °C. Cultures were inoc-
ulated and grown in 2-liter Erlenmeyer flasks at 37 °C in 750ml
of LB medium until A600 was 0.3–0.5. Then, isopropyl -D-1-
thiogalactosidewas added to a final concentration of 0.3mM for
the induction of expression at 17 °C for 16 h. Cells were har-
vested by centrifugation. The cell pellet was resuspended in a
buffer containing 50 mM HEPES, pH 8.0, and 500 mM NaCl
added with 25 g/ml of DNase and 2 mM PMSF, and lysed by
sonication. Insoluble debris was removed by centrifugation at
70,000 g for 40 min at 4 °C and the soluble lysate clarified by
filtration through a 0.45-m syringe filter. The resulting super-
natant was loaded on a Ni2-affinity column (5 ml HisTrapTM
FF, GE Healthcare) by an Åkta purifier (GE Healthcare) and
washed with the resuspending buffer added with 5 mM imidaz-
ole to remove the main part of contaminants. Elution of the
protein occurred at 100mM imidazole. STMO-containing frac-
tions were dialyzed overnight at 4 °C in 50mMHEPES/HCl, pH
8.0, 500mMNaCl in the presence of SUMOprotease to remove
the N-terminal tag. A further Ni2-affinity column separated
the native STMO from the cleaved tag and the protease. To
increase the sample homogeneity for crystallization purposes, a
final step of size exclusion chromatography (Superdex 75
16/60, GE Healthcare) was performed in 50 mM HEPES/HCl,
pH 7.5, 100 mMNaCl. The protein purity was assessed by SDS-
PAGEandbymeasurement of the ratio in the absorbance at 280
and 457 nm, which was about 9 for pure samples.
Mutagenesis—Site-directed mutagenesis was performed
using the PfuUltra Hotstart PCRMaster Mix (Agilent) accord-
ing to the manufacturer’s instructions. Primer sequences were
generated using the QuikChange tool available from Agilent
and are available upon request. As the mutants tended to
release FAD, the purification protocolwas slightlymodified. All
the buffers used to resuspend the cell pellet and for affinity
chromatography were added with 6% (w/v) glycerol, whereas
the amount of NaCl was lowered to 200 mM. Moreover, a small
excess of FAD (100–300 M) was added to the samples before
sonication and during dialysis.
Crystallization—For crystallization experiments, the puri-
fied proteins were dialyzed against 15 mMHEPES/HCl, pH 7.5,
30 mM NaCl, and concentrated up to 15–20 mg/ml. STMO
crystals were grown by the vapor diffusion method at 295 K.
Initial crystallization conditions were screened by the sitting-
drop technique using sparse matrix kits (Crystal Screen and
Crystal Screen 2, Hampton Research, CA) with an automated
device (Oryx8, Douglas Instruments). Positive hits were refined
using the hanging drop vapor-diffusion technique to identify
the optimal crystallization conditions: 2–4 l of protein solu-
tion mixed with equal volumes of reservoir solution consisting
of 1.8–2.2 MMgSO4, 0.1 MMES/HCl, pH 6.2–6.5. The protein
solution was supplemented with 0.5 mM FAD and, if needed,
with 2–5 mM NADP. Yellow, diffraction quality crystals grew
in 3–4 weeks. Crystals were directly flash-cooled in liquid
nitrogen, without any cryo-protecting agent in addition to
MgSO4.
X-ray Diffraction Data Collection and Structure Determin-
ation—Diffraction data of the native crystals were collected at
100 K on the PXII beamline at SLS (Villigen, Switzerland) and
on the ID23-2 and ID14-4 beamlines at ESRF (Grenoble,
France). All the data were processed with MOSFLM (18) and
programs of the CCP4 suite (19). The structure of STMO was
solved using the diffraction data of unliganded wild-type
enzyme by molecular replacement with PHASER (20) using
PAMO as search model (PDB code 1W4X (9)). The model was
refined manually through successive rounds using Coot (21),
whereas maximum likelihood refinement were carried out by
Refmac5 (22). The STMOapoenzymemodel was used as a tem-
plate to solve the other STMO structures. All final models were
validated with MolProbity, which did not detect any outliers in
the Ramachandran plot (23). Data collection and refinement
statistics are listed in Table 1. Pictures were generated with
PyMOL.
Steady-state Kinetics—Activities of the purified enzymes
were determined spectrophotometrically by monitoring the
decrease of the NADPH concentration by measuring the
absorbance at 340 nm. The reaction mixture (200 or 1000 l)
contained 50 mM Tris/HCl, pH 7.5, 100 M NADPH, 5% (v/v)
Me2SO in the case of phenylacetone or 5% (v/v) dioxane in the
case of progesterone, 0–16mMphenylacetone or 0–75Mpro-
gesterone, and 0.05–0.2 M enzyme. Kinetic parameters were
obtained by fitting the data to Equation 1 using SigmaPlot 11.
Standard errors in curve fitting were generally less than 10%
and duplos were within 10%. The kcat/Km values for progester-
onewere determined from the substrate-concentration-depen-





Phenylacetone and progesterone conversion was also checked
by gas-chromatography methods, as described (6).
RESULTS
Crystallographic Analysis and Overall Structure—Recombi-
nant STMO fromR. rhodochrouswas crystallized usingmagne-
sium sulfate as precipitant (Table 1). We obtained four crystal
structures (2.4–2.9 Å resolution): the wild-type enzyme in the
oxidized state and in complexwithNADP, and two active-site
mutants K295A and T345L. Except for the amino acid replace-
ments, these four models are essentially indistinguishable (root
mean square deviations below 0.2 Å for C atoms) and we shall
refer mainly to the NADP complex for the analysis of the
enzyme three-dimensional structure (Figs. 1 and supplemental
Fig. S1).
STMO exhibits the typical two-domain organization of the
other known BVMO enzymes, with each domain featuring the
dinucleotide-binding topology (Fig. 1). Structural comparisons
SteroidMonooxygenase from R. rhodochrous
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indicate that FAD- and NADP-binding domains of STMO
superimpose onto the corresponding domains of PAMO (7)
with root mean square deviations for the C atoms of 1.1 and
1.6 Å, respectively (Fig. 2). These close similarities reflect the
high 53% sequence identity between the two proteins. A slightly
lower but nevertheless strong degree of structural similarity
(root mean square deviations below 2.0 Å) is indicated also by
comparisons with the known crystal structures of other BVMO
enzymes (CHMO and OTEMO (11, 12)), which is in full agree-
ment with their (40%) sequence identities with STMO. The
only variations are small changes in the mutual orientations of
the two domains that rotate by 4–6°. Similar domain rotations
have been observed in other BVMO structures and probably
reflect intrinsic domain flexibility and, possibly, also the differ-
ent crystal packing environments. As found in the known
BVMO structures, the flavin of STMO shows virtually no devi-
ation from planarity (Fig. 4 and supplemental Fig. S1). In the
logic of our study, the close similarities highlighted by these
comparisons provide an excellent structural framework for
exploring the factors that control the diverse substrate selectiv-
ities among these enzymes. Along this line, we shall now
describe the STMO active site.
NADP Binding and Active Site—The crystal structure of
STMOexhibits a globular open pocket at the interface between
the two domains to form the binding site for NADP(H) and the
steroid substrate (Fig. 1). The two ligand-binding sites are
located on opposite walls of the cleft and converge in front of
the flavin (Figs. 2 and 3). STMO crystals were also obtained in
the presence of an excess of NADP, which enabled the struc-
ture determination of the enzyme bound to the coenzyme
ligand (Table 1 and supplemental Fig. S1). NADP binds in the
typical conformation observed in dinucleotide-binding pro-
teins, with the pyrophosphate group interacting with the N ter-
minus of the -helix of the  unit of the NADP-binding
domain (Figs. 1 and 2). The nicotinamide-ribose group is close
to a conserved Arg (Arg-342; Fig. 3), which is essential in catal-
ysis by favoring substrate oxygenation possibly through stabili-
zation of the tetrahedral Criegee intermediate (7).
An interesting observation concerns the precise binding
mode of the nicotinamide ringwith respect to the flavin (Fig. 2).
The coenzyme nicotinamide ring is located above the flavin
with the carbamide group pointing toward and in direct contact
with the central ring of the prosthetic group. The nicotinamide
remains partly solvent-accessible and within 4.5 Å distance
from Asp-71. The interactions with the solvent and the prox-
imity of the Asp-71 side chain can compensate for the NADP
positive charge. The functional implications for this conforma-
tion are effectively revealed by the comparison of STMO with
PAMO, OTEMO, and CHMO structures. The comparative
analysis indicates that the nicotinamide of STMO is promi-
nently shifted away from the flavin compared with the other
enzymes (Fig. 2). This observation is fully consistent with the
“sliding” model proposed by Mirza et al. (11). The nicotina-
TABLE 1
Crystallographic data collection and refinement statistics
STMOapo STMOox STMO-K295A STMO-T345L
PDB code 4AOX 4AOS 4AP1 4AP3
Unit cell (a, b, c) (Å) 79.76, 79.76, 222.98 81.56, 81.56, 224.52 82.16, 82.16, 228.81 81.75, 81.75, 228.07
Space group P 41 21 2 P 41 21 2 P 41 21 2 P 41 21 2
Resolution (Å) 2.4 2.5 2.9 2.4
Rsyma,b (%) 10.2 (47.2) 6.7 (15.1) 10.5 (50.8) 7.3 (26.5)
Completenessb (%) 99.9 (100.0) 99.5 (99.6) 99.9 (100.0) 99.5 (100.0)
Unique reflections 28,420 26,952 17,319 31,403
Redundancyb 6.8 (7.4) 12.6 (13.4) 7.9 (8.1) 7.7 (7.7)
I/b 11.4 (3.5) 25.1 (14.3) 14.4 (4.1) 16.6 (6.1)
No. of atoms 4324 4349 4022 4232
Rcrystc (%) 22.5 19.9 20.2 20.9
Rfreec (%) 25.2 23.6 24.9 23.9
Root mean square bond length (Å) 0.020 0.021 0.015 0.021
Root mean square bond angles (°) 1.94 1.93 1.48 1.92
a Rsym Ii I	/Ii, where Ii is the intensity of ith observation and I	 is the mean intensity of the reflection.
b Values in parentheses are for reflections in the highest resolution shell.
c Rcryst Fobs Fcalc/Fobs, where Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively. Rcryst and Rfree were calculated using the work-
ing and test set, respectively.
FIGURE 1. Overall structure of R. rhodochrous STMO. FAD and the NADP
are depicted in yellow and orange, respectively. The (partly disordered) loop
500–520 is shown in orange. From the comparison with other Baeyer-Villiger
enzyme structures, this loop is expected to change conformation to a
“closed” state during catalysis (1, 7, 9, 11, 24). The FAD-binding domain (bot-
tom) comprises residues 20–161 and 395–549, whereas the NADP domain is
formed by residues 162–394. Residues 1–19 and 510–516 (connected by a
dashed line) are disordered.
SteroidMonooxygenase from R. rhodochrous
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mide, anchored to the protein by the ADP segment of NADPH,
is able to slide into the active site to first bind above the flavin
with the proper geometry to perform hydride transfer. After
this catalytic step, the nicotinamidemoves further to eventually
adopt the position (red carbons in Fig. 2) that is instrumental to
the formation and stabilization of the flavin-peroxide interme-
diate after reaction of the reduced flavin with dioxygen.
NADP is locked in this flavin-peroxide promoting conforma-
tion by closure of an active site loop, which likely occurs only
after flavin reduction (see Refs. 1, 7, 9, 11, and 24 for a discus-
sion on this aspect of catalysis). In STMO, this loop protrudes
out of the protein and is partly disordered (residues 510–516;
Fig. 1), which is similar to the cases of PAMO in the unligated
form (7) and CHMO in the “open” conformation (green in Fig.
2) (11). Thus, the STMO crystals (obtained by co-crystallizing
the oxidized enzyme with NADP) reveal a binding mode that
is likely adopted by the reduced nicotinamide in the process of
attaining the conformation that affords reduction of the pros-
thetic FAD cofactor and, possibly, also by the oxidized NADP
in the process of being released by the enzyme, which is the last
step of the reaction.
Substrate-binding Site and Substrate Specificity—The ration-
ale behind this study was to investigate STMO in comparison
with PAMO and other well characterized BVMOs to gain
insight into the substrate selectivities of these enzymes. In this
regard, the crucial starting observation for our analysis was that
atomic superpositions clearly indicated that the active site of
STMO (Fig. 3a) is closely related to those of other BVMOs, and
in particular, to that of PAMO (Fig. 4a and supplemental Fig.
S2). As shown in Fig. 4a, the C traces of the residues lining the
active-site of STMO and PAMO are very similar, with shifts
between the C positions of homologous residuesmostly in the
0.2–0.4 Å range. The only clear variation concerns the loop
286–295 (STMO numbering), whose position is significantly
shifted in the two proteins. This loop is located above the
active-site pocket and is most likely directly involved in sub-
strate binding (Fig. 4a). Otherwise, the comparative inspection
of the 24 residues that are within 8 Å from the flavin N5 atom
(Table 2 and Fig. 4b) indicates that 12 side chains are conserved
between PAMO and STMO.
On these bases, we probed STMO and PAMO for their reac-
tivity toward their reciprocal reference substrates, progester-
one and phenylacetone. PAMOwas found to be unable to con-
vert progesterone but, remarkably, we observed that STMO
displays significant Baeyer-Villiger activity on phenylacetone.
Although theKm value is10 times higher compared with that
displayed by PAMO, these experiments unambiguously indi-
cate that STMO can now be reported to be a relatively efficient
phenylacetone monooxygenase (Table 3). Consequently, the
active site of STMO features a rather impressive level of prom-
iscuity in its substrate preference considering the vastly differ-
ent nature of progesterone and phenylacetone compounds.
AMutagenesis Study of STMOActive Site—The logical ques-
tion raised by the above described findings concerned the struc-
tural basis of these broad substrate activities and the possibility
to modulate them by site-directed mutagenesis. We have
repeatedly attempted the determination of the STMO struc-
ture in complex with progesterone or related molecules. Many
experimental strategies were tried but the poor solubility of
these compounds prevented success in these experiments.
For this reason, we adopted a different approach based on
mutating side chains that are part of the active site. The strategy
for choosing the mutations was to probe different types of vari-
ations targeting both hydrophobic (Val-72, Pro-157, Val-291,
Leu-500) and hydrophilic (Lys-295, Thr-345) residues andwith
different degrees of conservations in the other structurally
characterized BVMO enzymes (Tables 2 and 3). Furthermore,
the sites of mutations were located in different areas of the
active site, particularly with regard to their distance from the
flavin ring (see Figs. 3b and 4, a and b). Thus, V72I mimics
PAMO (which has Ile in this position) and affects a residue in
direct contact with the pyrimidine ring of the flavin. This resi-
FIGURE 2. Structural comparison of Baeyer-Villiger monooxygenases. Left, overall superposition between the backbones of STMO (blue) and PAMO (red).
The superpositionwas carriedout using the FADandNADPdomains of PAMOas independent units to emphasize theoverall similarity of the tertiary structures
(root mean square deviations of 1.1 Å for 295 C atoms and of 1.6 Å for 232 C atoms of the two domains, respectively). Right, close-up view of the active site
region. The picture shows the different positions of the nicotinamide ring of NADP in STMO (carbons in blue), CHMO (carbons in green; open conformation of
PDB entry 3GWF), PAMO (carbons in red; PDB entry 2YLR), and OTEMO (carbons in pink; PDB entry 3UOY, chain A). C ribbons of the four proteins are shown
together with the FAD of STMO.
SteroidMonooxygenase from R. rhodochrous
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due is in further contact with Val-291, which is positioned on
the only small active-site segment whose backbone conforma-
tion differs significantly between STMO and PAMO (Fig. 4a).
Its conservative replacement to Ala was designed to probe the
role of this differing area of the active site in substrate selectiv-
ity. Pro-157, Lys-295, Thr-345, and Leu-500weremutated with
the idea of targeting residues that, by being further away from
the flavin, could have a role in binding the bulky progesterone
thereby having a specific role in substrate specificity of STMO
(Fig. 3b). The mutants were all evaluated for their activities
on phenylacetone and progesterone, whose poor solubility
allowed us only to accurately measure kcat/Km values (Table 3).
Furthermore, two mutants (K295A and T345L) were subjected
to crystallographic studies (Table 1). In this way, a comprehen-
sive analysis of the substrate binding region could be obtained.
The main and, to a certain extent, most surprising theme
emerging from the analysis is that the effect of themutations on
FIGURE 3. STMO active site. a, the NADP- and flavin-binding regions. FAD
and NADP carbons are depicted with yellow and orange carbons, respec-
tively. b, spatial distribution of the sites targeted by our mutagenesis studies
(see Table 3) on the active site cavity. The C atoms of the mutated residues
are shownasblue spheres. Thr-345 and Lys-295 are highlighted in redbecause
mutations targeting these amino acids exhibited strong functional perturba-
tions and were subjected to crystallographic studies (Tables 1 and 3). Bluish
areas highlight the mutations exposed on the cavity surface. For the sake of
clarity, only the ribose andnicotinamide ringofNADP are depicted. Arg-342
is the crucial residue involved in the oxygen-insertion step during catalysis.
The cavity was calculated with a probe of 1.3-Å radius using Voidoo (27).
FIGURE4.Structural framework tosubstratebinding inSTMOandrelated
enzymes. a, superposition of STMO (blue ribbon) and PAMO (red ribbon)
active sites. FAD and NADP of STMO are shown. The C atoms of the STMO
residues targetedbymutagenesis are outlined as blue spheres (Table 3). b, the
Cpositions of residueswithin 8Ådistance from the flavinN5atomson the re
side of the cofactor (Table 2). The blue spheres (cyan for mutated residues;
Table 3) identify STMO residues that have the side chains oriented toward the
active site and differ from the corresponding residues of PAMO, CHMO, and
OTEMO.
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enzymatic activities is relatively modest. In all cases, mutations
did not affect the NADPH oxidase (uncoupling) activity, i.e. the
consumption ofNADPH in the absence of the organic substrate
caused by the NADPH-mediated flavin reduction followed by
reoxidation to generate hydrogen peroxide. This indicates that
flavin reactivity in terms of both reduction by NADPH and
oxygen-mediated reoxidation is unaffected by the mutations,
which is consistent with the strategy of targeting residues that
are part of the substrate-binding site and not expected to have a
direct role in redox catalysis. Similar to the wild-type protein,
kcat values for progesterone and phenylacetone for most of the
mutants were at least 10 times higher than the rates of uncou-
pling (Table 3). This is in full agreement with the general func-
tional properties of BVMOs. These enzymes stabilize the fla-
vin-peroxide intermediate that, without a substrate, decays
slowly to generate hydrogen peroxide, whereas the decay is
greatly accelerated by the binding of the oxygen-accepting sub-
strate. Furthermore, themutant proteins exhibitedminor alter-
ations on the activity on phenylacetone in comparison to the
wild-type enzyme. Likewise, using progesterone as substrate
did not highlight drastic changes, although it is of note that
three (V72I, K295A, L500Y) mutants displayed higher activity
on this compound, with K295A being three times more active
than the wild-type enzyme (Table 3). The only clear exception
is T345L, which turned out to make STMO inactive against
progesterone without altering the catalytic efficiency for phe-
nylacetone (Table 3). On this basis, the crystal structures of the
two more functionally perturbed mutants, T345L and K295A,
were solved (Table 1 and Figs. 3b and 4a). They did not show
any conformational change except for the replacement of the
side chains, suggesting that the analyzedmutations, by affecting
residues exposed on the surface of the active-site cleft, do not
generally cause significant structural perturbations.
These data are intriguing because at least some of the muta-
tions (P157Q, K295A, L500Y) correspond to rather drastic side
chain replacements that can be expected to alter charge distri-
bution and hydrophobicity of the walls lining the binding site.
Inspection of the three-dimensional structure shows that bulky
progesterone can be accommodated in the active site in various
orientations and poses that would be compatible with catalysis.
We refrain from presenting an in silicomodel of a bound pro-
gesterone given the many uncertainties, above all concerning
the exact conformational state of the substrate-bound enzyme
(e.g. the conformation of loop 510–516, which is disordered in
our crystals of STMO, and uncertainty of howNADP is bound
in the substrate-enzyme complex; Fig. 1). Despite this limita-
tion, the lack of activity of T345Lonprogesterone indicates that
this residue is probably involved in forming a productive
enzyme-progesterone complex. The bulkier Leu side chain of
the mutant may hinder proper binding of the steroid in the
active site. This effect is instead seemingly absent for the
smaller phenylacetone substrate. This is the only clue from
these studies for the presence of a relatively specific enzyme-
substrate interaction that can greatly alter substrate binding.
Indeed, the limited effects on steady-state parameters by all
other mutations indicate that none of the targeted side chains
and binding site areas (at least individually) are essential or even
truly crucial for the recognition and catalytically productive
binding of both progesterone and phenylacetone.
DISCUSSION
BVMOshave a fascinatingmechanism that has been clarified
by several studies (1, 7). The enzymatic function is based on the
dual role of NADP(H), which acts as flavin reductant as well as
an integral part of the active site that promotes oxygen activa-
tion and oxygenation. Thismechanism implies that the enzyme
must exist in different functional/conformational states includ-
TABLE 2
Analysis of the aminoacid variationsbetween the active sites of STMO
and related enzymes
All listed residues are within 8 Å distance from the flavin N5 atom on the re side of
the cofactor and their side chains are oriented toward the active-site cavity (see Fig.
4b). PAMO, CHMO, or OTEMO residues that are conserved in STMO are high-
lighted in boldface.
STMO PAMO CHMO OTEMO
Val-59 Val-54 Thr-47 Thr-47
Ala-68 Ala-63 Ala-56 Cys-56
Cys-70 Cys-65 Ser-58 Leu-58
Asp-71 Asp-66 Asp-59 Asp-59
Val-72a Ile-67 Thr-60 Thr-60
Pro-157a Gln-152 Leu-145 Pro-145
Leu-158 Leu-153 Leu-146 Leu-146
Ser-201 Ser-196 Ser-188 Ala-195
Ser-202 Ser-197 Thr-189 Thr-196
Asn-225 His-220 Gln-212 Asn-219
Val-261 Thr-256 Phe-248 Phe-255
Val-291a Pro-286 Phe-279 Tyr-285
Lys-295a Ala-290 Phe-283 Leu-289
Arg-342 Arg-337 Arg-329 Arg-337
Val-344 Ile-339 Leu-331 Pro-339
Thr-345a Leu-340 Cys-332 Met-340
Met-397 Leu-392 Val-385 Val-392
Ser-446 Ser-441 Ser-441
Val-447 Ala-442 Thr-442
Leu-448 Leu-443 Phe-434 Phe-443
Met-451 Met-446 Leu-437 Val-446
Leu-500a Tyr-495 Phe-486 Leu-495
Trp-506 Trp-501 Trp-492 Trp-501
Pro-521 Leu-516 Phe-507 Val-519
a Residues targeted by mutagenesis in this study.
TABLE 3
Kinetic parameters for STMOmutants
WT V72I P157Q V291A K295A T345L L500Y PAMOa
Phenylacetone
kcat (s1) 1.5 2.7 0.6 1.8 3.0 0.2 1.0 3.1
Km (mM) 1.0 0.6 0.2 0.8 2.6 0.2 0.5 0.08
kcat/Km (mM1 s1) 1.5 4.7 2.6 2.2 1.2 1.2 2.1 39
Progesteroneb
kcat/Km (mM1 s1) 1.8 3.9 1.7 1.4 5.2 
0.1 4.7 
0.1
Uncouplingc (s1) 0.08 0.11 0.09 0.04 0.13 0.10 0.10 0.02
a From Ref. 6.
b Due to solubility limitations, the kcat and Km values for progesterone could not be determined.
c Uncoupling refers to NADPH oxidation in the absence of phenylacetone or progesterone substrates.
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ing one that promotes NADPH-mediated reduction of the
flavin and one that promotes formation and stabilization of the
oxygen-activating flavin-peroxide intermediate, which is
essential for substrate oxygenation. These catalytic steps are
brought about by conformational changes, at least locally
affecting the active site (11, 12). The structure of STMO is fully
consistent with this picture by showing a NADP-binding
mode in which the nicotinamide is shifted outward, away from
the flavin (Fig. 2). In particular, this observation provides a fur-
ther indication in support of the idea thatNADP(H)mustmove
above the flavin along the catalytic cycle to carry out its dual
function in catalysis. A certain degree of flexibility between the
two protein domainsmay be further instrumental to the attain-
ment of the active site conformations that are responsible for
performing the various catalytic steps and accommodating the
substrates.
A remarkable finding of our study is the fact that STMO,
initially discovered as progesterone monooxygenase, is also
active on phenylacetone (Scheme 1 andTable 3). This feature is
matched by the close structural similarities exhibited by STMO
and PAMO active sites (Figs. 2–4). Moreover, of the six sub-
strate-binding site mutants that were generated, only one had a
clear effect on activity on at least one of the two substrates. All
the other mutants display steady-state parameters that are
comparable with those of wild-type STMO, highlighting a
remarkable robustness of the system (17) (Table 3). These find-
ings are especially puzzling in light of the self-evident differ-
ences between phenylacetone and progesterone in terms of
size, bulkiness, hydrophobicity, and hydrogen-bonding groups
(Scheme 1). The mutagenesis, kinetic, and structural data do
not offer clues for the presence of elements or niches in the
binding site that recognize specific chemical and structural fea-
tures on these substrates. Rather, the emerging idea is that the
binding site, which is mainly (but not exclusively) decorated by
small aliphatic side chains (Table 2), functions as a sort of gen-
eral hydrophobic selectivity filter.
This notion is supported by the enhanced activity against
progesterone (but not phenylacetone) displayed by K295A,
which removes a positive charge from a site of the binding
pocket that is at a distance of 8 Å from the flavin (Fig. 3). Both
progesterone andphenylacetone can be oxygenated, apparently
because their ketone group linked to a hydrophobic/aliphatic
moiety that can gain access to the reacting center in front of the
flavin. This does not imply that any molecule can be processed
by any BVMO. For example, PAMO is not active on progester-
one. Likewise, cyclohexanone, the substrate of the closely
related CHMO, does not show any detectable Bayer-Villiger
conversion by STMO or PAMO (25). The lower degree of
hydrophobicity but relatively higher degree of conformational
flexibility of this cyclic aliphatic molecule may require more
specific interactions to be productively bound by the enzyme.
On the other hand, as shown by a recent extensive substrate-
profile analysis of BVMOs (24), STMO displays some activity
on cyclohexanone derivatives such as 2-phenylcyclohexanone
and 2-propylcyclohexanone that carry hydrophobic substitu-
ents. In other words, there is substrate selectivity and prefer-
ence, with, however, a considerable level of promiscuity as
effectively indicated by the acceptance of both progesterone
and phenylacetone by STMO.A key point that will be subject to
further studies is the dynamics and flexibility of the active site,
especially with regard to the role of conformational adaptability
(26). The substrate preference is apparently the result of the
balance of relatively nonspecific, mostly hydrophobic, interac-
tions that the groups on the surface of the binding site are able
to establish with the substrate ligands.
These features likely reflect the plasticity of these enzymes
that keep evolving in the microbial world in response to the
emerging availabilities of new compounds. It remains fascinat-
ing that the relatively limited number of mutations can enable
an enzyme to acquire a catalytic function on a very different
molecule, possibly retaining the ability to act on the original
substrate. These findings support even further the idea that the
BVMO enzymes of the STMO/CHMO/PAMO group are par-
ticularly attractive for user-tailored protein engineering stud-
ies. Their robust scaffold and promiscuity in substrate prefer-
ences indicate that they have a clear evolutionary potential to be
exploited for generation of variants with activities on desired
substrates, suited for Baeyer-Villiger oxidations.
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